Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
[F1]2021-01-04$4.85/sh−115$558→ 17,256 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 01/01/2021.
Signature
/s/ Sarah Romano, Attorney-in-Fact*|2021-01-05